Respiratory (Lung, Bronchus) System Archives

Patients

HCPs

Germline Testing: The Therapeutic Biomarker You Can’t Afford to Miss

Post category:Breast Cancer Digestive (CRC, Stomach) System Genitourinary (Prostate, Bladder) System Gynecologic Cancer Melanoma Respiratory (Lung, Bronchus) System
Reading time:2 mins read

You may already be ordering germline testing at rates well above the national average — but across the U.S., most eligible patients still aren’t tested: Ovarian cancer: ~39% receive germline…

Consolidative nivolumab versus observation in unresectable stage III non-small cell lung cancer patients following neoadjuvant nivolumab plus chemotherapy and concurrent chemoradiotherapy (CA209-7AL): a randomized clinical trial.

Post category:Respiratory (Lung, Bronchus) System
Reading time:1 min read

The CA209-7AL phase 2 trial evaluated the efficacy and safety of consolidative nivolumab (NIVO) versus observation after...

Real-world effectiveness and safety of treatment strategies for unresectable, driver-negative Stage III NSCLC: A retrospective multicentre study.

Post category:Respiratory (Lung, Bronchus) System
Reading time:1 min read

This multicenter retrospective study involving 960 patients with unresectable, driver gene-negative Stage III NSCLC from...

Updates in Lung Cancer Screening: A Decade of Evidence.

Post category:Respiratory (Lung, Bronchus) System
Reading time:1 min read

The publication with DOI 10.1055/a-2701-9312 provides a comprehensive review of recent evidence in lung cancer screening...

The American Cancer Society National Lung Cancer Roundtable strategic plan: Tobacco treatment in the context of lung cancer screening.

Post category:Respiratory (Lung, Bronchus) System
Reading time:1 min read

The publication associated with DOI 10.1002/cncr.35972 addresses the critical gap in effectively integrating tobacco dep...

How ACCURE Closed Racial Survival Gaps in Cancer — And How CMS PIN Codes Scale It

Post category:Breast Cancer Pan Cancer Respiratory (Lung, Bronchus) System Supportive Oncology
Reading time:4 mins read

You’ve seen the survival gaps. You’ve felt the impact. And the question that follows is both urgent and fair:What exactly can you do about it — in your clinic, with…